Placebo-controlled trial of the CCK-B antagonist, CI-988, in panic disorderPANDE, A. C; GREINER, M; ADAMS, J. B et al.Biological psychiatry (1969). 1999, Vol 46, Num 6, pp 860-862, issn 0006-3223Article

Association studies of the cholecystokinin B receptor and A2a adenosine receptor genes in panic disorderYAMADA, K; HATTORI, E; SHIMIZU, M et al.Journal of neural transmission. 2001, Vol 108, Num 7, pp 837-848, issn 0300-9564Article

The cholecystokinin-B receptor antagonist L-740,093 produces an insurmountable antagonism of CCK-4 stimulated functional response in cells expressing the human CCK-B receptorDUNLOP, J; PASS, I; ENNIS, C et al.Neuropeptides (Edinburgh). 1998, Vol 32, Num 2, pp 157-160, issn 0143-4179Article

Effects of peripheral axotomy on cholecystokinin neurotransmission in the rat spinal cordANTUNES BRAS, J. M; LAPORTE, A.-M; BENOLIEL, J. J et al.Journal of neurochemistry. 1999, Vol 72, Num 2, pp 858-867, issn 0022-3042Article

Glycine-extended gastrin regulates HEK cell growthSTEPAN, V. M; KRAMETTER, D. F; MATSUSHIMA, M et al.American journal of physiology. Regulatory, integrative and comparative physiology. 1999, Vol 46, Num 2, pp R572-R581, issn 0363-6119Article

The cholecystokinin_B receptor is coupled to two effector pathways through pertussis toxin-sensitive and -insensitive G proteinsPOMMIER, B; NASCIMENTO, S. D; DUMONT, S et al.Journal of neurochemistry. 1999, Vol 73, Num 1, pp 281-288, issn 0022-3042Article

Peripheral axotomy influences the in vivo release of cholecystokinin in the spinal cord dorsal horn-possible involvement of cholecystokinin-B receptorsGUSTAFSSON, H; DE ARAUJO LUCAS, G; SCHÖTT, E et al.Brain research. 1998, Vol 790, Num 1-2, pp 141-150, issn 0006-8993Article

Involvement of CCK in the paraventricular nucleus of the hypothalamus in the cns regulation of colonic motilityMÖNNIKES, H; TEBBE, J; GROTE, C et al.Digestion. 2000, Vol 62, Num 2-3, pp 178-184, issn 0012-2823Article

Evidence for a functional role of the cholecystokinin-B/gastrin receptor in the human fetal and adult pancreasSAILLAN-BARREAU, C; DUFRESNE, M; TARASOVA, N et al.Diabetes (New York, NY). 1999, Vol 48, Num 10, pp 2015-2021, issn 0012-1797Article

Effects of the CCK_B antagonist CI-988 on responses to mCPP in generalized anxiety disorderGODDARD, A. W; WOODS, S. W; MONEY, R et al.Psychiatry research. 1999, Vol 85, Num 3, pp 225-240, issn 0165-1781Article

Cholecystokinin modulates the aversive component of morphine withdrawal syndrome in ratsVALVERDE, O; ROQUES, B. P.Neuroscience letters. 1998, Vol 244, Num 1, pp 37-40, issn 0304-3940Article

The role of spinal cholecystokinin B receptors in thermal allodynia and hyperalgesia in diabetic miceKAMEI, Junzo; ZUSHIDA, Ko.Brain research. 2001, Vol 892, Num 2, pp 370-375, issn 0006-8993Article

Cholecystokinin_B receptor antagonist increases food intake in ratsDORRE, D; SMITH, G. P.Physiology & behavior. 1998, Vol 65, Num 1, pp 11-14, issn 0031-9384Article

Cholecystokinin B-type receptor signaling is involved in human pancreatic cancer cell growthKAUFMANN, R; SCHAFBERG, H; RUDROFF, C et al.Neuropeptides (Edinburgh). 1997, Vol 31, Num 6, pp 573-583, issn 0143-4179Conference Paper

Antinociceptive effect of U-50488H, a κ-opioid agonist, in streptozotocin-induced diabetic miceSUZUKI, Yasuyuki; GOTO, Kazuhiro; SHIIZAKI, Kazuhiro et al.Journal of pharmacy and pharmacology. 2001, Vol 53, Num 4, pp 521-526, issn 0022-3573Article

Disruption of cholecystokinin (CCK)-B receptor gene did not modify bile or Pancreatic secretion or Pancreatic growth : A study in CCK-B receptor gene knockout miceMIYASAKA, K; SHINOZAKI, H; KONO, A et al.Pancreas. 1999, Vol 19, Num 2, pp 114-118, issn 0885-3177Article

Cognitive enhancing effects in young and old rats of pBC₂₆₄, a selective CCK_B receptor agonistTAGHZOUTI, K; LENA, I; DELLU, F et al.Psychopharmacologia. 1999, Vol 143, Num 2, pp 141-149, issn 0033-3158Article

CCK receptor antagonistsDUNLOP, J.General pharmacology. 1998, Vol 31, Num 4, pp 519-524, issn 0306-3623Article

Gastric effects of the CCK-B/gastrin receptor ligand CI-988 in cynomolgus monkeysDETHLOFF, L. A; PATMORE, S. J; TIERNEY, B. M et al.Food and chemical toxicology. 1998, Vol 36, Num 1, pp 61-71, issn 0278-6915, 10 p.Article

CCK-B receptors produce similar signals but have opposite growth effects in CHO and Swiss 3T3 cellsDETJEN, K; YULE, D; TSENG, M.-J et al.American journal of physiology. Cell physiology. 1997, Vol 42, Num 5, pp C1449-C1457, issn 0363-6143Article

Gastrin and gastrin receptor activation: an early event in the adenoma-carcinoma sequenceSMITH, A. M; WATSON, S. A.Gut. 2000, Vol 47, Num 6, pp 820-824, issn 0017-5749Article

Concurrent chronic administration of a CCK_B antagonist can decrease tolerance to the ataxic effects of ethanolWILSON, J; WOODRUFF, G. N; LITTLE, H. J et al.Addiction biology. 1999, Vol 4, Num 1, pp 35-45, issn 1355-6215Article

The enhancement of morphine antinociception by a CCK_B receptor antagonist in the rat depends on the phase of inflammation and the intensity of carrageenin-induced hyperalgesiaPERROT, S; IDÄNPÄÄN-HEIKKILÄ, J. J; GUILBAUD, G et al.Pain (Amsterdam). 1998, Vol 74, Num 2-3, pp 269-274, issn 0304-3959Article

La G17 et la G17-gly stimulent la prolifération des cellules LoVo par l'intermédiaire du récepteur CCK B/gastrine = Gastrin-17 and G17-gly induce proliferation through activation of CCK B/gastrin receptor in LoVo cellsARTRU, P; ATTOUB, S; LEVASSEUR, S et al.Gastroentérologie clinique et biologique. 1998, Vol 22, Num 6-7, pp 607-612, issn 0399-8320Article

CCK_B antagonists protect against anxiety-related behaviour produced by ethanol withdrawal, measured using the elevated plus mazeWILSON, J; WATSON, W. P; LITTLE, H. J et al.Psychopharmacologia. 1998, Vol 137, Num 2, pp 120-131, issn 0033-3158Article